Peptides that inhibit the interaction between ASF1 and histones, and use thereof
US9526757B2 · kind B2 · utility
0Cited by
0References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 16, 2012 |
| Grant date | Dec 27, 2016 |
| Priority date | — |
| Expiry date | Nov 16, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to peptides capable of inhibiting the formation of the complex between the Asf1 histone chaperone and histones H3-H4, and to the use thereof as a drug, particularly for treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.